Lamistar 30 mg (Lamivudine/Stavudine)
| Active Ingredient | Lamivudine/Stavudine |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Hetero Drugs Ltd |
| Packaging | 60 tablets in 1 bottle |
| Strength | 180mg |
| Delivery Time | 6 To 15 days |
Lamistar 30 mg is a fixed-dose combination antiretroviral medication containing Lamivudine and Stavudine, both classified as nucleoside reverse transcriptase inhibitors (NRTIs). This medication is used in combination with other antiretroviral drugs to treat HIV-1 infection by blocking the reverse transcriptase enzyme, thereby preventing the virus from multiplying.
Though older in the spectrum of HIV drugs, Lamistar remains a valuable option in specific cases where modern therapies are unavailable or contraindicated.








There are no reviews yet.